SynthesisClinical rheumatology2017

Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.

Maria Izabel de Holanda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.